Recent Finacing
Recent Raise
Elucida Oncology develops ultra-small C’Dot–Drug–Conjugates engineered for precise tumor targeting and deep penetration to deliver highly potent drugs to difficult-to-treat tumors while minimizing systemic exposure and off-target toxicity.